Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Intratumoral injection of EFEMP1-derived tumor suppression protein shows promise for brain cancer

Dec. 23, 2015

MEDI-3039: a potential therapeutic for TNBC

Dec. 23, 2015

Cell therapy improves functional and structural outcome after muscle trauma

Dec. 23, 2015

MAPKK inhibitor shows potential for the treatment of cancer cachexia

Dec. 23, 2015

Cerulean's tunable nanoparticle-drug conjugates are safe and effective antitumor agents

Dec. 23, 2015

Accurin nanoformulations improve antitumor activity and PK/PD profile

Dec. 23, 2015

OLIG2 pathway inhibitors show promise for the treatment of glioblastoma

Dec. 22, 2015

E-selectin antagonist GMI-1271 advances to study in leukemia patients

Dec. 22, 2015

ABP-980 proved similar to FDA-licensed trastuzumab

Dec. 21, 2015

Interim phase I results of SGN-LIV1A

Dec. 21, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026